197 related articles for article (PubMed ID: 19957378)
61. Mitochondrial Toxic Effects of Antiepileptic Drug Valproic Acid on Mouse Kidney Stem Cells.
Lee M; Ahn C; Kim K; Jeung EB
Toxics; 2023 May; 11(5):. PubMed ID: 37235285
[TBL] [Abstract][Full Text] [Related]
62. Valproic Acid and Breast Cancer: State of the Art in 2021.
Wawruszak A; Halasa M; Okon E; Kukula-Koch W; Stepulak A
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298623
[TBL] [Abstract][Full Text] [Related]
63. Window-of-Opportunity Study of Valproic Acid in Breast Cancer Testing a Gene Expression Biomarker.
Cohen AL; Neumayer L; Boucher K; Factor RE; Shrestha G; Wade M; Lamb JG; Arbogast K; Piccolo SR; Riegert J; Schabel M; Bild AH; Werner TL
JCO Precis Oncol; 2017; 1():. PubMed ID: 32913974
[TBL] [Abstract][Full Text] [Related]
64. Effect of chronic valproic Acid treatment on hepatic gene expression profile in wfs1 knockout mouse.
Punapart M; Eltermaa M; Oflijan J; Sütt S; Must A; Kõks S; Schalkwyk LC; Fernandes C; Vasar E; Soomets U; Terasmaa A
PPAR Res; 2014; 2014():349525. PubMed ID: 24799886
[TBL] [Abstract][Full Text] [Related]
65. Autophagy and hepatic stellate cell activation - partners in crime?
Hsu CC; Schwabe RF
J Hepatol; 2011 Dec; 55(6):1176-7. PubMed ID: 21856271
[No Abstract] [Full Text] [Related]
66. Correction:
Contis-Montes de Oca A; Rodarte-Valle E; Rosales-Hernández MC; Abarca-Rojano E; Rojas-Hernández S; Fragoso-Vázquez MJ; Mendieta-Wejebe JE; Correa-Basurto AM; Vázquez-Moctezuma I; Correa-Basurto J
Oncotarget; 2019 Feb; 10(11):1225. PubMed ID: 30838095
[TBL] [Abstract][Full Text] [Related]
67. Sodium valproate blocks the transforming growth factor (TGF)-β1 autocrine loop and attenuates the TGF-β1-induced collagen synthesis in a human hepatic stellate cell line.
Watanabe T; Tajima H; Hironori H; Nakagawara H; Ohnishi I; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Tani T; Fujimura T; Ota T; Wakayama T; Iseki S; Harada S
Int J Mol Med; 2011 Dec; 28(6):919-25. PubMed ID: 21822535
[TBL] [Abstract][Full Text] [Related]
68. Efficient low-cost chromatin profiling with CUT&Tag.
Kaya-Okur HS; Janssens DH; Henikoff JG; Ahmad K; Henikoff S
Nat Protoc; 2020 Oct; 15(10):3264-3283. PubMed ID: 32913232
[TBL] [Abstract][Full Text] [Related]
69. Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis.
Zheng D; Jiang Y; Qu C; Yuan H; Hu K; He L; Chen P; Li J; Tu M; Lin L; Chen H; Lin Z; Lin W; Fan J; Cheng G; Hong J
Am J Pathol; 2020 Nov; 190(11):2267-2281. PubMed ID: 32805235
[TBL] [Abstract][Full Text] [Related]
70. TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019.
Dewidar B; Meyer C; Dooley S; Meindl-Beinker AN
Cells; 2019 Nov; 8(11):. PubMed ID: 31718044
[TBL] [Abstract][Full Text] [Related]
71. Peak calling by Sparse Enrichment Analysis for CUT&RUN chromatin profiling.
Meers MP; Tenenbaum D; Henikoff S
Epigenetics Chromatin; 2019 Jul; 12(1):42. PubMed ID: 31300027
[TBL] [Abstract][Full Text] [Related]
72. Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin.
DeWaal D; Nogueira V; Terry AR; Patra KC; Jeon SM; Guzman G; Au J; Long CP; Antoniewicz MR; Hay N
Nat Commun; 2018 Jan; 9(1):446. PubMed ID: 29386513
[TBL] [Abstract][Full Text] [Related]
73. Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies.
San José-Enériz E; Agirre X; Rabal O; Vilas-Zornoza A; Sanchez-Arias JA; Miranda E; Ugarte A; Roa S; Paiva B; Estella-Hermoso de Mendoza A; Alvarez RM; Casares N; Segura V; Martín-Subero JI; Ogi FX; Soule P; Santiveri CM; Campos-Olivas R; Castellano G; de Barrena MGF; Rodriguez-Madoz JR; García-Barchino MJ; Lasarte JJ; Avila MA; Martinez-Climent JA; Oyarzabal J; Prosper F
Nat Commun; 2017 May; 8():15424. PubMed ID: 28548080
[TBL] [Abstract][Full Text] [Related]
74. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.
Mederacke I; Hsu CC; Troeger JS; Huebener P; Mu X; Dapito DH; Pradere JP; Schwabe RF
Nat Commun; 2013; 4():2823. PubMed ID: 24264436
[TBL] [Abstract][Full Text] [Related]
75. STAR: ultrafast universal RNA-seq aligner.
Dobin A; Davis CA; Schlesinger F; Drenkow J; Zaleski C; Jha S; Batut P; Chaisson M; Gingeras TR
Bioinformatics; 2013 Jan; 29(1):15-21. PubMed ID: 23104886
[TBL] [Abstract][Full Text] [Related]
76. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration.
Thorvaldsdóttir H; Robinson JT; Mesirov JP
Brief Bioinform; 2013 Mar; 14(2):178-92. PubMed ID: 22517427
[TBL] [Abstract][Full Text] [Related]
77. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer's disease.
Pan RY; He L; Zhang J; Liu X; Liao Y; Gao J; Liao Y; Yan Y; Li Q; Zhou X; Cheng J; Xing Q; Guan F; Zhang J; Sun L; Yuan Z
Cell Metab; 2022 Apr; 34(4):634-648.e6. PubMed ID: 35303422
[TBL] [Abstract][Full Text] [Related]
78. A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis.
Blaha CS; Ramakrishnan G; Jeon SM; Nogueira V; Rho H; Kang S; Bhaskar P; Terry AR; Aissa AF; Frolov MV; Patra KC; Brooks Robey R; Hay N
Nat Commun; 2022 Feb; 13(1):899. PubMed ID: 35173161
[TBL] [Abstract][Full Text] [Related]
79. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases.
Moreno-Yruela C; Zhang D; Wei W; Bæk M; Liu W; Gao J; Danková D; Nielsen AL; Bolding JE; Yang L; Jameson ST; Wong J; Olsen CA; Zhao Y
Sci Adv; 2022 Jan; 8(3):eabi6696. PubMed ID: 35044827
[TBL] [Abstract][Full Text] [Related]
80. Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy.
Tan Z; Sun H; Xue T; Gan C; Liu H; Xie Y; Yao Y; Ye T
Front Cell Dev Biol; 2021; 9():730176. PubMed ID: 34621747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
